2024 Annual Meeting Program 

The 2024 ACCP Annual Meeting Program Committee, led by Drs. Amit Pai and Catherijne Knibbe, invites you to Save the Date for the 2024 ACCP Annual Meeting, September 8th – 10th at the Bethesda N Marriott Hotel & Conference Ctr in N Bethesda, MD. The 2024 ACCP Annual Meeting will help you stay in the forefront of your field with a series of high-quality, relevant educational events designed to meet the needs of the global clinical pharmacology community. Evening Poster Sessions & Receptions provide a relaxing atmosphere to explore scientific Posters and network with colleagues, new and old.   

CME & CPE credits will be available to all attendees and a series of Student, Trainee & Early-stage Professional-focused events provide unique opportunities for young colleagues to become part of the greater clinical pharmacology community and engage with career professionals who are eager to share their experiences and answer questions.

Put us on your calendar as THE meeting you will attend in 2024!

    

 Educational Sessions   

Saturday, September 7th

Pre-meeting Workshop (full day): Physiologically-based Pharmacokinetic Analyses: A Workshop on Practical Applications in Clinical Drug Development

Trends in Drug Development (full day): Designed to meet the needs of industry colleagues, this event will cover a series of current, impactful topics faced by colleagues in industry and regulatory roles.

Sunday, September 8th

Plenary Session: Speaker TBD

Symposium 1: Clinical Pharmacology of Cannabinoids:  Drug Development & Public Health Implications

Symposium 2: Facilitating Drug Discovery & Development Using AI/Machine Learning, An ACCP & ASPET Joint Educational Event

Symposium 3: Assessing the Impact of Obesity During Drug Development: What Can We Do Better?

Symposium 4: Advances in Improving Pediatric Therapeutic Response

Monday, September 9th

Symposium 5: Animal Alternatives: Current Landscape in Organoids, Organ-on-a-chip & Microfluidic Systems - How do we Fully Leverage this Unique Opportunity to Transform Drug Development?

Symposium 6: Increasing Diversity in Clinical Trials: What Will it Take for Us to Close the Gap?

Invited Keynote: Speaker TBD

Symposium 7: Operational Considerations for Early-phase Pharmacokinetic/Pharmacodynamic/Safety Studies in Pediatric Patients

Symposium 8: Harmonization of the Bioequivalence Assessments for the Narrow Therapeutic Index Drugs: Delivering the Promise to Patients

Symposium 9: Rethinking Hepatic Impairment Studies: A Patient Centric Approach

Symposium 10: Hot Topics

Tuesday, September 10th

Symposium 11: Hot Topics

Symposium 12: Towards Optimal Dosing in Malnutrition: What Can We Do Better?

Symposium 13: Advancements in Understanding Drug-Induced Hypersensitivity Reactions

Symposium 14: At the Precipice of Induction-based Drug-Drug Interactions: An Opportunity to Define the Path Forward

Symposium 15: Project Optimus: A Paradigm Shift in Quantitative Clinical Pharmacology or a Business As Usual?

Symposium 16: New Perspectives on Drug Evaluation in Older Adults

Symposium 17: Hot Topics